Company Quick10K Filing
ICU Medical
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 22 $5,345
10-Q 2019-11-12 Quarter: 2019-09-30
10-Q 2019-08-09 Quarter: 2019-06-30
10-Q 2019-05-10 Quarter: 2019-03-31
10-K 2019-03-01 Annual: 2018-12-31
10-Q 2018-11-09 Quarter: 2018-09-30
10-Q 2018-08-09 Quarter: 2018-06-30
10-Q 2018-05-10 Quarter: 2018-03-31
10-K 2018-03-16 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-09-30
10-Q 2017-08-09 Quarter: 2017-06-30
10-Q 2017-05-12 Quarter: 2017-03-31
10-K 2017-03-01 Annual: 2016-12-31
10-Q 2016-11-09 Quarter: 2016-09-30
10-Q 2016-08-09 Quarter: 2016-06-30
10-Q 2016-05-10 Quarter: 2016-03-31
10-K 2016-02-26 Annual: 2015-12-31
10-Q 2015-11-05 Quarter: 2015-09-30
10-Q 2015-08-10 Quarter: 2015-06-30
10-Q 2015-05-06 Quarter: 2015-03-31
10-K 2015-02-20 Annual: 2014-12-31
10-Q 2014-11-10 Quarter: 2014-09-30
10-Q 2014-08-11 Quarter: 2014-06-30
10-Q 2014-05-07 Quarter: 2014-03-31
10-K 2014-02-21 Annual: 2013-12-31
10-Q 2013-10-22 Quarter: 2013-09-30
10-Q 2013-07-25 Quarter: 2013-06-30
10-Q 2013-04-22 Quarter: 2013-03-31
10-K 2013-02-26 Annual: 2012-12-31
10-Q 2012-10-19 Quarter: 2012-09-30
10-Q 2012-07-20 Quarter: 2012-06-30
10-Q 2012-04-20 Quarter: 2012-03-31
10-K 2012-03-23 Annual: 2011-12-31
10-Q 2011-10-21 Quarter: 2011-09-30
10-Q 2011-07-22 Quarter: 2011-06-30
10-Q 2011-04-22 Quarter: 2011-03-31
10-K 2011-02-18 Annual: 2010-12-31
10-Q 2010-10-22 Quarter: 2010-09-30
10-Q 2010-07-23 Quarter: 2010-06-30
10-Q 2010-04-23 Quarter: 2010-03-31
10-K 2010-02-19 Annual: 2009-12-31
8-K 2019-12-31 Officers, Exhibits
8-K 2019-11-12 Earnings, Exhibits
8-K 2019-08-07 Earnings, Exhibits
8-K 2019-07-08 Officers, Exhibits
8-K 2019-05-16 Shareholder Vote
8-K 2019-05-09 Earnings, Exhibits
8-K 2019-04-05 Officers
8-K 2019-03-04 Officers
8-K 2019-02-28 Earnings, Exhibits
8-K 2018-11-15 Other Events, Exhibits
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-08-09 Earnings, Exhibits
8-K 2018-05-15 Officers, Shareholder Vote
8-K 2018-05-09 Earnings, Exhibits
8-K 2018-03-01 Earnings, Exhibits
8-K 2018-01-05 Officers

ICU Medical Financials

ICUI Metrics, Comps, Filings

Annual | Quarterly

Business

First person pronouns used in this Report, such as "we," "us," and "our," refer to ICU Medical, Inc. ("ICU") and its subsidiaries unless context requires otherwise.

ICU was founded in 1984 and our initial public offering was in 1992. Our headquarters are in San Clemente, California. In 1993, we launched the Clave™, an innovative one-piece needlefree intravenous ("IV") connection device. Since the late 1990's, we have expanded our product offerings by introducing internally developed products and systems. Key developments have included the MicroClave Clear™ connector as an update to the Clave, Tego™ needlefree connector for use in hemodialysis, products for handling hazardous drugs including the ChemoClave™ and ChemoLock™ CSTDs ("closed-system transfer devices", the Diana™ hazardous drug compounding system, and the Neutron®, a catheter patency device.

In October 2015, we acquired Excelsior Medical Corporation's SwabCap® disinfecting cap for needlefree IV connectors to enhance our direct and OEM infusion therapy product offerings and to open new customer opportunities globally.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Insulet (PODD) 7,136 66% 163.9 2% 978 728 661 435 17 47 7,624
Hill-Rom Holdings (HRC) 7,067 49% 25.9 5% 4,575 2,951 2,884 1,415 215 335 8,663
Haemonetics (HAE) 6,085 46% 35.9 4% 1,260 669 977 450 49 176 6,331
Penumbra (PEN) 6,047 67% 257.6 3% 585 131 495 332 15 23 5,969
Novocure (NVCR) 5,679 72% -357.0 -10% 406 247 294 212 -41 -16 5,646
ICU Medical (ICUI) 5,345 39% 39.5 3% 1,623 305 1,311 508 47 127 5,031
Integra Lifesciences (IART) 4,669 62% 20.6 3% 3,290 1,869 1,493 930 101 262 5,393
Globus Medical (GMED) 4,300 77% 18.9 10% 1,391 103 743 573 143 221 4,182
Cantel Medical (CMD) 3,630 47% 30.3 5% 1,070 409 918 427 55 126 3,816
Tandem Diabetes Care (TNDM) 3,601 52% -70.5 -22% 255 110 282 147 -55 -49 3,470
Merit Medical Systems (MMSI) 3,357 45% 26.4 2% 1,736 786 949 423 39 141 3,722
Nuvasive (NUVA) 3,283 72% 19.4 3% 1,805 1,127 814 52 194 3,765
Glaukos (GKOS) 2,779 87% -384.5 -4% 302 114 211 182 -12 -7 2,730
Nevro (NVRO) 1,957 69% -26.5 -21% 448 246 379 261 -93 -77 2,049
iRhythm Technologies (IRTC) 1,941 75% -48.5 -21% 207 159 182 137 -44 -40 1,923
Cardiovascular Systems (CSII) 1,490 81% 334.2 -0% 219 71 248 200 -0 4 1,416
Inspire Medical Systems (INSP) 1,451 82% -63.2 -14% 186 33 64 52 -25 -23 1,424
Atricure (ATRC) 1,174 73% -164.1 -6% 343 102 216 158 -20 -7 1,189
CryoLife (CRY) 1,123 66% 37.2 1% 597 315 271 179 3 35 1,307
Tactile Systems Technology (TCMD) 1,058 70% 68.0 7% 122 23 166 116 8 15 1,033

Balance Sheet ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash10893160226297347377445300382
Accounts Receivable4855444945395856113176
Inventory4144403634374449289311
PP&E7784838688867486399433
Assets3093123614295005416277051,4971,585
Accounts Payable181113111111141578120
Long-Term Debt
Liabilities413835334745299322
Stockholders' Equity3213914655085806601,1981,264
Income Statement ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue2312843023163133093413791,2921,400
Cost of Revenue122153159160158157160178866830
Gross Profit109131142157155151181201426570
R&D35911121816135153
SG&A6877858590898389304328
Tax131822211292321-17-6
Net Income27314541402645636929
Cash Flow ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating4933646666615590154160
Cash Investing-3520-46-41-13-22-1116-267-103
Cash Financing-18-232222419252-448